SPIRIVA HandiHaler 18 mcg Inhalation Powder
RxNorm 580261
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 580261 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: SPIRIVA HandiHaler 18 mcg Inhalation Powder.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SYPrescribable
Synonym (SY):
Spiriva HandiHaler 18 mcg (tiotropium bromide 22.5 mcg) Inhalation Powder
(Atom ID: 12751185)
PSNPrescribable
Prescribable Name (PSN):
SPIRIVA HandiHaler 18 mcg Inhalation Powder
(Atom ID: 12751187)
SYPrescribable
Synonym (SY):
Spiriva HandiHaler 18 mcg Inhalation Powder
(Atom ID: 12751186)
SBDPrescribable
Semantic Branded Drug (SBD):
Tiotropium 0.018 mg Inhalation Powder [Spiriva]
(Atom ID: 10788915)
Patient Education
Tiotropium Oral Inhalation
Tiotropium is used to prevent wheezing, shortness of breath, coughing, and chest tightness in patients with chronic obstructive pulmonary disease (COPD, a group of diseases that affect the lungs and airways) such as chronic bronchitis (swelling of the air passages that lead to the lungs) and emphysema (damage to air sacs in the lungs). Tiotropium is in a class of medications called bronchodilators. It works by relaxing and opening the air passages to the lungs to make breathing easier.
[Learn More]
* Please review the disclaimer below.